«Спасительные» методы лечения рака предстательной железы после радикальной терапии

«Спасительные» методы лечения рака предстательной железы после радикальной терапии

Автор: Сивков А.В., Муравьев В., Кешишев Н.Г., Шадеркин И.А., Шкабко О.В.

Журнал: Экспериментальная и клиническая урология @ecuro

Рубрика: Дискуссия

Статья в выпуске: 4, 2010 года.

Бесплатный доступ

Рак предстательной железы, местный рецидив,

Короткий адрес: https://sciup.org/142188240

IDR: 142188240

Список литературы «Спасительные» методы лечения рака предстательной железы после радикальной терапии

  • Анализ уронефрологической заболеваемости в Российской Федерации по данным официальной статистики/Аполихин О.И., Сивков А.В., Бешлиев Д.А., Солнцева Т.В., Комарова В.А.//Экспериментальная и клиническая урология. №1. 2010
  • Пушкарь Д.Ю., Говоров А.В., Бормотин А.В. Простат-специфический антиген и биопсия предстательной железы. М. 2003. 160 с.
  • Алексеев. Б. Я., Калпинский А. С. Роль простатоспецифического антигена в диагностике рака предстательной железы//Российский онкологический журнал: научно-практический журнал. 2007. № 6. С. 43-46.
  • Итоги Московской программы «Диспансеризация мужского населения по выявлению заболеваний предстательной железы/Максимов А.А., Прохоров А.В., Борисик В.И., Рябой А.В., Евсеев А.В.//Материалы ХI Съезда Российского общества урологов. М. 2007. С. 183-184.
  • Ранняя диагностика и лечение больных локализованным раком простаты/Журавлев В.Н., Баженов И.В., Зырянов А.В., Коган О.С., Вахлов С.Г., Борзунов И.В., Качмазов А.А., Машковцев А.В.//Материалы ХI Съезда Российского общества урологов. М. 2007. С. 153-154.
  • Management of prostate-specifc antigen relapse in prostate cancer: a European Consensus/Boccon-Gibod L., Djavan W.B., Hammerer P., Hoeltl W., Kattan M.W., Prayer-Galetti T., Teillac P., Tunn U.W.//Int J Clin Pract. 2004. Vol. 58, №4. P. 382-390.
  • Moul J.W. Prostate specifc antigen only progression of prostate cancer//J Urol. 2000. Vol. 163. № 6. P. 1632-1642.
  • Defning biochemical recurrence of prostate cancer afer radical prostatectomy: a proposal for a standardized defnition/Stephenson A.J., Kattan M.W., Eastham J.A., Dotan Z.A., Bianco Jr. F.J., Lilja H., Scardino P.T.//J Clin Oncol. 2006. Vol. 24. № 24. P. 3973-3978.
  • Guidelines on Prostate Cancer/Heidenreich A., Bolla M., Joniau S., Mason M.D., Matveev V., Mottet N., Schmid H-P., van der Kwast T.H., Wiegel T., Zattoni F. 2010.
  • American Society for Terapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy//Int J Radiat Oncol Biol Phys. 1997. Vol. 37. № 5. P. 1035-1041.
  • Defning biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference./Roach III M., Hanks G., Tames Jr H., Schelhammer P., Shipley W.U., Sokol G.E., Sandler H.//Int J Radiat Oncol Biol Phys. 2006. Vol. 65. № 4. P. 965-974.
  • Aus G. Current status of HIFU and cryotherapy in prostate cancer -a review//Eur Urol. 2006. Vol. 50. № 5. P. 927-934.
  • Long-term biochemical disease-free and cancerspecifc survival following anatomic radical retropubic prostatectomy. Te 15-year Johns Hopkins experience/Han M., Partin A.W., Pound C.R., Epstein J.I., Walsh P.C.//Urol Clin North Am. 2001. Vol.28. № 3. P. 555-565.
  • Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation/Rosser C.J., Chichakli R., Levy L.B., Kuban D.A., Smith L.G., Pisters L.L.//J Urol. 2002. Vol. 168. № 2. P. 536-541.
  • Defnitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled/Horwitz E.M., Tames H.D., Kuban D.A., Levy L.B., Kupelian P.A., Martinez A.A., Michalski J.M., Pisansky T.M., Sandler H.M., Shipley W.U., Zelefsky M.J., Hanks G.E., Zietman A.L.//J Urol. 2005. Vol. 173. № 3. P. 797-802.
  • Te relationship of ultrasensitive measurements of prostate-specifc antigen levels to prostate cancer recurrence afer radical prostatectomy/Taylor J. III, Kof S.G., Dauser D.A., McLeod D.G.//BJU Int. 2006. Vol. 98. № 3. P. 540-543.
  • Recommendations for Post-Prostatectomy Radiation Terapy in the United States Before and Afer the Presentation of Randomized Trials./Hofman K.E., Nguyen P.L., Chen M.H., Chen R.C., Choueiri T.K., Hu J.C., Kuban D.A., D'Amico A.V.//J Urol. 2010. Vol. 184.
  • Management of prostate-specifc antigen relapse in prostate cancer: a European Consensus/Boccon-Gibod L., Djavan W.B., hammerer P., Hoeltl W., Kattan M.W., Prayer-Galetti T., Teillac P., Tunn U.W.//Int J Clin Pract. 2004. Vol. 58. № 4. P. 382-390.
  • Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy afer radiation and for radiation therapy with rising prostate-specifc antigen levels afer radical prostatectomy. American Society for Terapeutic Radiology and Oncology Consensus Panel/Cox J.D., Gallagher M.J., Hammond E.H., Kaplan R.S., Schellhammer P. F.//J Clin Oncol. 1999. Vol. 17. № 4. P. 1155-1163.
  • Vaidya A., Soloway M.S. Salvage radical prostatectomy for radiorecurrent prostate cancer: morbidity revisited//J Urol. 2000. Vol. 164. № 6. P. 1998-2001.
  • Shekarriz B., Upadhyay J., Pontes J.E. Salvage radical prostatectomy//Urol Clin North Am. 2001. Vol. 28. № 3. P. 545-553.
  • Eastham J.A., DiBlasio C.J., Scardino P.T. Salvage radical prostatectomy for recurrence of prostate cancer radiation therapy//Curr Urol Rep. 2003. Vol. 4. № 3. P. 211-215.
  • Te efcacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specifc antigen/Wu J.J., King S.C., Montana G.S., McKinstry C.A., Anscher M.S.//Int J Radiat Oncol Biol Phys. 1995. Vol. 32. № 2. P. 317-323.
  • Te use of radiotherapy or patients with isolated elevation of prostate specifc antigen following radical prostatectomy/Schild S.E., Buskirk S.J., Wong W.W., Halyard M.Y., Swanson S.K., Novicki D.E., Ferrigni R.G.//J Urol. 1996. Vol. 156. № 5. P. 1725-1729.
  • Terapeutic irradiation for patients with an elevated postprostatectomy prostate specifc antigen level/Forman J.D., Meetze K., Pontes E., Wood D.P., Shamsa F., Rana T., Porter A.T.//J Urol. 1997. Vol. 158. № 4. P. 1436-1439.
  • Radiotherapy afer radical prostatectomy: treatment outcomes and failure patterns/Nudell D.M., Grossfeld G.D., Weinberg V.K., Roach M. 3rd, Carroll P.R.//Urology. 1999. Vol. 54. № 6. P. 1049-1057.
  • Salvage radiotherapy for men with isolated rising PSA or local palpable recurrence after radical prostatectomy: do outcomes difer?/MacDonald O.K., Schild S.E., Vora S., Andrews P.E., Ferrigni R.G., Novicki V., Swanson S.K., Wong W. W.//Urology. 2004. Vol.64. № 4. P. 760-764.
  • Predominant treatrment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794./Swanson G.P., Hussey M.A., Tangen C.M., Chin J., Messing E., Canby-Hagino E., Forman J.D., Tompson I.M., Crawford E.D.//J Clin Oncol. 2007. Vol. 25. № 6. P. 222-229.
  • Predicting outcome of salvage radiation therapy for recurrent prostate cancer afer radical prostatectomy./Stephenson A.J., Scardino P.T., Kattan M.W., Pisansky T.M., Slawin K.M., Klein E.A., Anscher M.S., Michalski J.M., Sandler H.M., Lin D.W., Forman J.D., Zelefsky M.J., Kestin L.L., Roehrborn C.G., Catton C.N., DeWeese T.L., Liauw S.L., Valicenti R.K., Kuban D.A., Pollack A.//J Clin Oncol. 2007. Vol. 25. № 15. P. 2035-2041.
  • Limited suppression of prostate specifc antigen afer salvage radiotherapy for its isolated elevation afer radical prostatectomy./Egewa S., Matsumoto K., Suyama K., Soh S., Kuwao S., Iwamura M.//Urology. 1999. Vol. 53. № 1. P. 148-155.
  • Salvage radiotherapy afer high-intensity focused ultrasound for localized prostate cancer: early clinical results/Pasticier G., Chapet O., Badet L., Ardiet J.M., Poissonnier L., Murat F.J., Martin X., Gelet A.//Urology. 2008. Vol. 72. № 6. P. 1305-1309.
  • Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes/Ward J.F., Sebo T.J., Blute M.L., Zincke H.//J Urol. 2005. Vol. 173. № 4. P. 1156-1160.
  • Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer afer radiotherapy./. Bianco F.J. Jr., Scardino P.T., Stephenson A.J., Diblasio C.J., Fearn P.A., Eastham J.A.//Int J Radiat Oncol Biol Phys. 2005. Vol. 62. № 2. P. 448-453.
  • Stephenson A.J., Eastha J.A. Role of salvage radical prostatectomy for recurrent prostate cancer afer radiation therapy//J Clin Oncology. 2005. Vol 23. № 3210. P. 8198-8203.
  • Impact of prior prostate radiation on complications afer radicalpProstatectomy/Gotto G.T., Yuis L.H., Vora K., Eastham J.A., Scardino P.T., Rabbani F.//J Urol. 2010. Vol. 184. № 1. P. 136-142.
  • Treatment of patients afer failed high intensity focused ultrasound and radiotherapy for localized prostate cancer: salvage laparoscopic extraperitoneal radical prostatectomy/Liatsikos E., Bynens B., Rabenalt R., Kallidonis P., Do M., Stolzenburg J.U.//J Endourol. 2008. Vol. 22. № 10. P. 2295-2298.
  • Grampsas S.A., Miller G.J., Crawford E.D. Salvage radical prostatectomy afer failed transperineal cryotherapy: histologic fndings from prostate whole-mount specimens correlated with intraoperative transrectal ultrasound images//Urology. 1995. Vol. 45. № 6. P. 936-941.
  • Beyer D.C. Salvage brachytherapy afer external-beam irradiation for prostate cancer//Oncology. 2004. Vol.18. № 2. P. 151-158.
  • Salvage brachytherapy for localized prostate cancer afer radiotherapy failure/Grado G.L., Collins J.M., Kriegshauser J.S., Balch C.S., Grado M.M., Swanson G.P., Larson T.R., Wilkes M.M., Navickis R.J.//Urology. 1999. Vol. 53. № 1. P. 2-10.
  • Lee H.K., Adams M.T., Motta J. Richmond salvage prostate brachytherapy for localized prostate cancer failure afer external beam radiation therapy//Brachytherapy. 2008. Vol. 7. № 1. P. 17-21.
  • Long-term outcome and toxicity of salvage brachytherapy for local failure afer initial radiotherapy for prostate cancer./Burri R.J., Stone N.N., Unger P., Stock R.G.//Int J Radiat Oncol Biol Phys. 2010. Vol. 77. № 5. P. 1338-1344.
  • Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence afer radiotherapy: Te University of California-San Francisco experience/Lee B., Shinohara K., Weinberg V., Gottschalk A.R., Pouliot J., Roach M. 3rd, Hsu I.C.//Int J Radiat Oncol Biol Phys. Vol. 7. № 4. P. 1106-1112.
  • Best practice statement on cryosurgery for the treatment of localized prostate cancer/Babaian R. J., Donnelly B., Bahn D., Baust J. G, Dineen M., Ellis D., Katz A., Pisters L., Rukstalis D., Shinohara K., Trasher J. B.//J Urol 2008. Vol. 180. P. 1993-2004.
  • Salvage cryotherapy for recurrent prostate cancer afer radiation failure: a prospective case series of the frst 100 patients/Ismail M, Ahmed S, Kastner C, Davies J.//BJU Int. 2007. Vol. 100. № 4. P. 760-764.
  • Langenhuijsen J.F., Broers E.M., Vergunst H. Cryosurgery for Prostate Cancer: an Update on Clinical Results of Modern Cryotechnology//Eur Urol. 2009. Vol. 55. № 1. P. 52-55.
  • Mid-term results demonstrate salvage high-intensity focused ultrasound (HIFU) as an efective and acceptably morbid salvage treatment option for locally radiorecurrent prostate cancer/Murat F.J., Poissonnier L., Rabilloud M., Belot A., Bouvier R., Rouviere O., Chapelon J.Y., Gelet A.//Eur Urol. 2009. Vol. 55. № 3. P. 640-647.
  • Huang W.C. Minimally ablative therapies for salvage treatment following radiation therapy//Minimally Invasive Ablative Treatment of Prostate Cancer. June 25-26. 2010. New York, NY.
  • Rectal fstulae afer salvage high-intensity focused ultrasound for recurrent prostate cancer afer combined brachytherapy and external beam radiotherapy/Ahmed H.U., Ishaq A., Zacharakis E., Shaw G., Illing R., Allen C., Kirkham A., Emberton M.//BJU Int. 2009. Vol. 103. № 3. P. 321-323.
  • Hayashi M., Shinmei S., Asano K. Transrectal high-intensity focused ultrasound for treatment for patients with biochemical failure afer radical prostatectomy//Int J Urol. 2007. Vol. 14. № 11. P. 1048-1050.
  • Salvage high-intensity focused ultrasound for biopsy-confrmed local recurrence of prostate cancer afer radical prostatectomy.//Murota-Kawano A., Nakano M., Hongo S., Shoji S., Nagata Y., Uchida T./BJU Int. 2010. Vol. 105. № 12. P. 1642-1645.
  • HIFU-терапия местного рецидива рака предстательной железы после простатэктомии/Сивков А.В., Кудрявцев Ю.В., Кешишев Н.Г., Шадеркин И.А., Щербинин С.Н.//Экспериментальная и клиническая урология. 2010. № 2. С. 68-71.
Еще
Статья
SciUp 2024 © 2024 ©